The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
Open accessAbstract
Cardiovascular pathologies maintain the leading position in mortality worldwide. Atherosclerosis is a chronic disease that can result in a variety of serious complications, such as myocardial infarction, stroke, and cardiovascular disease. Inflammation and lipid metabolism alterations play a crucial role in atherogenesis, but the details of relationships and causality of these fundamental processes remain not clear. The oxidation of LDL was considered the main atherogenic modification of LDL within the vascular wall for decades. However, recent investigations provided a growing body of evidence in support of the multiple LDL modification theory. It suggests that LDL particles undergo numerous modifications that change their size, density, and chemical properties within the blood flow and vascular wall. Oxidation is the last stage in this cascade resulting in the atherogenic properties. Moreover, recent investigations have discovered that oxLDL may have both anti-inflammatory and pro-inflammatory properties. Oxidized LDL can trigger inflammation through the activation of macrophages and other cells. After all, oxidized LDL is still a promising object for further investigations that have the potential to clarify the unknown parts of the atherogenic process. In this review, we discuss the role of oxLDL in atherosclerosis development on different levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443123 · Cited by 74
Self-citationRetractedHeart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Biochemistry of oxidative stress
Halliwell, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351147 · Cited by 1,543
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,519
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Henriksen, T., Mahoney, E. M., & Steinberg, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6499 · Cited by 1,021
NADPH oxidases: An overview from structure to innate immunity-associated pathologies
Panday, A., Sahoo, M. K., Osorio, D., & Batra, S. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.89 · Cited by 944
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
LOX-1, OxLDL, and Atherosclerosis
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 769
Mechanisms of foam cell formation in atherosclerosis
Chistiakov, D. A., Melnichenko, A. A., Myasoedova, V. A., Grechko, A. V., & Orekhov, A. N. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1575-8 · Cited by 742
Self-citationBekkering, S., Quintin, J., Joosten, L. A. B., van der Meer, J. W. M., Netea, M. G., & Riksen, N. P. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303887 · Cited by 726
Laursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721
Miller, Y. I., Choi, S.-H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.223875 · Cited by 646
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
Lipoproteins and atherogenesis. Current concepts
Steinberg, D. (1990) · JAMA · doi:10.1001/jama.264.23.3047 · Cited by 581
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562
Hörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Hessler, J. R., Robertson, A. L., & Chisolm, G. M. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90166-7 · Cited by 505
Oxidative stress and endothelial dysfunction in hypertension
Schulz, E., Gori, T., & Münzel, T. (2011) · Hypertension Research · doi:10.1038/hr.2011.39 · Cited by 502
The NADPH oxidase of professional phagocytes—prototype of the NOX electron transport chain systems
Cross, A. R., & Segal, A. W. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.03.008 · Cited by 489
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Levitan, I., Volkov, S., & Subbaiah, P. V. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2733 · Cited by 473
Steinberg, D., & Witztum, J. L. (2002) · Circulation · doi:10.1161/01.cir.0000014762.06201.06 · Cited by 471
Small Dense Low‐Density Lipoprotein as Biomarker for Atherosclerotic Diseases
Ivanova, E. A., Myasoedova, V. A., Melnichenko, A. A., Grechko, A. V., & Orekhov, A. N. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1273042 · Cited by 457
Self-citationNADPH Oxidases in Vascular Pathology
Konior, A., Schramm, A., Czesnikiewicz-Guzik, M., & Guzik, T. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 452
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
Witztum, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00111-6 · Cited by 440
MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response
Saba, R., Sorensen, D. L., & Booth, S. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00578 · Cited by 427
Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability
Nishi, K., Itabe, H., Uno, M., Kitazato, K. T., Horiguchi, H., Shinno, K., & Nagahiro, S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033829.14012.18 · Cited by 409
Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies
Yang, X., Li, Y., Li, Y., Ren, X., Zhang, X., Hu, D., Gao, Y., Xing, Y., & Shang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00600 · Cited by 404
New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis
Wu, M.-Y., Li, C.-J., Hou, M.-F., & Chu, P.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102034 · Cited by 392
Scavenger Receptor Structure and Function in Health and Disease
Zani, I., Stephen, S., Mughal, N., Russell, D., Homer-Vanniasinkam, S., Wheatcroft, S., & Ponnambalam, S. (2015) · Cells · doi:10.3390/cells4020178 · Cited by 361
Blair, A., Shaul, P. W., Yuhanna, I. S., Conrad, P. A., & Smart, E. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32512 · Cited by 360
Oxidized Low-Density Lipoprotein
Parthasarathy, S., Raghavamenon, A., Garelnabi, M. O., & Santanam, N. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60327-029-8_24 · Cited by 331
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview
Chen, C., Lü, J.-M., & Yao, Q. (2016) · Medical Science Monitor · doi:10.12659/msm.899852 · Cited by 302
Förstermann, U., & Li, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01196.x · Cited by 300
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
Xu, S., Ogura, S., Chen, J., Little, P. J., Moss, J., & Liu, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1194-z · Cited by 293
Bergmark, C., Wu, R., Faire, U. D., Lefvert, A. K., & Swedenborg, J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.441 · Cited by 280
Purification and characterization of a bovine acetyl low density lipoprotein receptor.
Kodama, T., Reddy, P., Kishimoto, C., & Krieger, M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9238 · Cited by 259
LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
Kattoor, A. J., Goel, A., & Mehta, J. L. (2019) · Antioxidants · doi:10.3390/antiox8070218 · Cited by 253
Tetrahydrobiopterin in Cardiovascular Health and Disease
Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M., & Crabtree, M. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5566 · Cited by 231
Liu, J., Thewke, D. P., Su, Y. R., Linton, M. F., Fazio, S., & Sinensky, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000148548.47755.22 · Cited by 225
Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Morimoto, M., Hayashida, K., Hashimoto, N., & Kita, T. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.955 · Cited by 215
Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages
Lara-Guzmán, O. J., Gil-Izquierdo, Á., Medina, S., Osorio, E., Álvarez-Quintero, R., Zuluaga, N., Oger, C., Galano, J.-M., Durand, T., & Muñoz-Durango, K. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.017 · Cited by 194
Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment
Poznyak, A. V., Grechko, A. V., Orekhova, V. A., Chegodaev, Y. S., Wu, W., & Orekhov, A. N. (2020) · Biology · doi:10.3390/biology9030060 · Cited by 191
Self-citationHuang, R.-S., Hu, G.-Q., Lin, B., Lin, Z.-Y., & Sun, C.-C. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181ff46d7 · Cited by 190
Role of Xanthine Oxidoreductase as an Antimicrobial Agent
Martin, H. M., Hancock, J. T., Salisbury, V., & Harrison, R. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.4933-4939.2004 · Cited by 188
LOX-1 in Atherosclerosis and Myocardial Ischemia
Pothineni, N. V. K., Karathanasis, S. K., Ding, Z., Arulandu, A., Varughese, K. I., & Mehta, J. L. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.010 · Cited by 184
How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses
Rhoads, J. P., & Major, A. S. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026483 · Cited by 183
Vitamin E and Cardiovascular Disease
Saremi, A., & Arora, R. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31819cdc9a · Cited by 166
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
Summerhill, V. I., Grechko, A. V., Yet, S.-F., Sobenin, I. A., & Orekhov, A. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143561 · Cited by 166
Self-citationCD40/CD40L signaling and its implication in health and disease
Chatzigeorgiou, A., Lyberi, M., Chatzilymperis, G., Nezos, A., & Kamper, E. (2009) · BioFactors · doi:10.1002/biof.62 · Cited by 164
Li, X., Kong, D., Chen, H., Liu, S., Hu, H., Wu, T., Wang, J., Chen, W., Ning, Y., Li, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep21789 · Cited by 161
Role for Nox1 NADPH oxidase in atherosclerosis
Sheehan, A. L., Carrell, S., Johnson, B., Stanić, B., Bánfi, B., & Miller, F. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.028 · Cited by 154
Oxidized low‐density lipoprotein in inflammation‐driven thrombosis
Obermayer, G., Afonyushkin, T., & Binder, C. J. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13925 · Cited by 141
Pendyala, S., Usatyuk, P. V., Gorshkova, I. A., Garcia, J. G. N., & Natarajan, V. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2231 · Cited by 133
The Dynamics of Oxidized LDL during Atherogenesis
Itabe, H., Obama, T., & Kato, R. (2011) · Journal of Lipids · doi:10.1155/2011/418313 · Cited by 130
OxLDL induces endothelial dysfunction and death via TRAF3IP2: Inhibition by HDL3 and AMPK activators
Valente, A. J., Irimpen, A. M., Siebenlist, U. K., & Chandrasekar, B. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.014 · Cited by 127
Chen, C., & Khismatullin, D. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123088 · Cited by 117
Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1
Chen, K., Hsieh, I.-C., Hsi, E., Wang, Y., Dai, C., Chou, W., & Juo, S. H. (2011) · Journal of Cell Science · doi:10.1242/jcs.092767 · Cited by 97
Fleißner, F., & Thum, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3502 · Cited by 97
Wu, R., & Lefvert, A. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06652.x · Cited by 94
LDL biochemical modifications: a link between atherosclerosis and aging
Alique, M., Luna, C., Carracedo, J., & Ramírez, R. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.29240 · Cited by 93
Doxaki, C., Kampranis, S. C., Eliopoulos, A. G., Spilianakis, C. G., & Tsatsanis, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500615 · Cited by 91
Lipid and Non-lipid Factors Affecting Macrophage Dysfunction and Inflammation in Atherosclerosis
Gibson, M. S., Domingues, N. S., & Vieira, O. V. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00654 · Cited by 90
Guo, C., Ma, R., Liu, X., Chen, T., Li, Y., Yu, Y., Duan, J., Zhou, X., Li, Y., & Sun, Z. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.02.312 · Cited by 86
miR-155 in the Resolution of Atherosclerosis
Bruen, R., Fitzsimons, S., & Belton, O. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00463 · Cited by 84
Hara, T., Phương, P. T., Fukuda, D., Yamaguchi, K., Murata, C., Nishimoto, S., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.033544 · Cited by 81
Vaccination Strategies and Immune Modulation of Atherosclerosis
Nilsson, J. Å., & Hansson, G. K. (2020) · Circulation Research · doi:10.1161/circresaha.120.315942 · Cited by 75
Dopp, J. M., Philippi, N. R., Marcus, N. J., Olson, E. B., Bird, C. E., Moran, J. J. M., Mueller, S. W., & Morgan, B. J. (2011) · Respiration · doi:10.1159/000329341 · Cited by 73
Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes
Younis, N. N., Soran, H., Pemberton, P. W., Charlton-Menys, V., Elseweidy, M. M., & Durrington, P. N. (2012) · Clinical Science · doi:10.1042/cs20120304 · Cited by 66
Immune Response to Lipoproteins in Atherosclerosis
Samson, S., Mundkur, L., & Kakkar, V. V. (2012) · Cholesterol · doi:10.1155/2012/571846 · Cited by 66
Oxidative mechanisms and atherothrombotic cardiovascular disease
Leopold, J. A., & Loscalzo, J. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.02.001 · Cited by 62
LDL and foam cell formation as the basis of atherogenesis
Orekhov, A. N. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000525 · Cited by 62
Self-citationAntioxidants in the Fight Against Atherosclerosis: Is This a Dead End?
Toledo-Ibelles, P., & Mas‐Oliva, J. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0737-7 · Cited by 58
Stress in Obesity and Associated Metabolic and Cardiovascular Disorders
Holvoet, P. (2012) · Scientifica · doi:10.6064/2012/205027 · Cited by 57
Lacraz, G., Rakotoarivelo, V., Labbé, S. M., Vernier, M., Noll, C., Mayhue, M., Staňková, J., Schwertani, A. G., Grenier, G., Carpentier, A. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162995 · Cited by 54
Immunität und Entzündung bei Arteriosklerose
Wolf, D., & Ley, K. F. (2019) · Herz · doi:10.1007/s00059-019-4790-y · Cited by 48
Alipov, V. I., Sukhorukov, V. N., Карагодин, В. П., Grechko, A. V., & Orekhov, A. N. (2017) · Vessel Plus · doi:10.20517/2574-1209.2017.20 · Cited by 47
Self-citationOrekhov, A. N., Nikiforov, N. G., Sukhorukov, V. N., Kubekina, M. V., Sobenin, I. A., Wu, W., Foxx, K. K., Pintus, S. S., Stegmaier, P., Stelmashenko, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030817 · Cited by 43
Self-citationOrekhov, A. N., Sukhorukov, V. N., Nikiforov, N. G., Kubekina, M. V., Sobenin, I. A., Foxx, K. K., Pintus, S. S., Stegmaier, P., Stelmashenko, D., Kel, A. E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082716 · Cited by 42
Self-citationRen, S. P., Hure, A. J., Peel, R., D’Este, C. A., Abhayaratna, W. P., Tonkin, A. M., Hopper, I., Thrift, A. G., Levi, C. R., Sturm, J. W., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.04.003 · Cited by 40
Degano, I. R., Subirana, I., García-Mateo, N., Cidad, P., Muñoz-Aguado, D., Puigdecanet, E., Nonell, L., Vila, J., Camps, A., Crepaldi, F. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051402 · Cited by 40
NLPR3 Inflammasomes and Their Significance for Atherosclerosis
Poznyak, A. V., Melnichenko, A. А., Wetzker, R., Герасимова, Е. В., & Orekhov, A. N. (2020) · Biomedicines · doi:10.3390/biomedicines8070205 · Cited by 39
Self-citationClarity on the Isoform-Specific Roles of NADPH Oxidases and NADPH Oxidase-4 in Atherosclerosis
Fulton, D. J., & Barman, S. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307096 · Cited by 38
The Relationship of Plasma miR-29a and Oxidized Low Density Lipoprotein with Atherosclerosis
Huang, Y., Cai, A., Chen, J., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453202 · Cited by 36
Zhang, C., Adamos, C., Oh, M., Baruah, J., Ayee, M. A. A., Mehta, D., Wary, K. K., & Levitan, I. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00249.2016 · Cited by 35
Wang, Y., Hsi, E., Cheng, H., Hsu, S., Liao, Y., & Juo, S. H. (2017) · Oncotarget · doi:10.18632/oncotarget.18197 · Cited by 29
Shekhar, S., Khan, R. S., Ferreira, D. M., Mitsi, E., German, E. L., Rørvik, G. H., Berild, D., Schenck, K., Kwon, K., & Petersen, F. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00747 · Cited by 25
Modified and Dysfunctional Lipoproteins in Atherosclerosis: Effectors or Biomarkers?
Orekhov, A. N., & Sobenin, I. A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180320121137 · Cited by 23
Self-citationFunctional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases
Kigawa, Y., Miyazaki, T., Lei, X., Kim‐Kaneyama, J., & Miyazaki, A. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33431 · Cited by 18
Lacraz, G., Rakotoarivelo, V., Labbé, S. M., Vernier, M., Noll, C., Mayhue, M., Staňková, J., Schwertani, A. G., Grenier, G., Carpentier, A. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166537 · Cited by 10
IL-15 and GM-CSF stimulated macrophages enhances phagocytic activity in ENU induced leukemic mice
Singha, A. K., Sarkar, C., Majumder, D., Debnath, R., Saha, M., & Maiti, D. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.12.003 · Cited by 7
Cited by
Free radicals and their impact on health and antioxidant defenses: a review
Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I., & Lee, S. J. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02278-8 · Cited by 669
Jiang, H., Zhou, Y., Nabavi, S. M., Sahebkar, A., Little, P. J., Xu, S., Weng, J., & Ge, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.925923 · Cited by 323
Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
Poznyak, A. V., Bharadwaj, D., Prasad, G., Grechko, A. V., Sazonova, M. A., & Orekhov, A. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136702 · Cited by 142
Self-citationEndothelial Dysfunction as the Common Pathway Linking Obesity, Hypertension and Atherosclerosis
Młynarska, E., Bojdo, K., Frankenstein, H., Krawiranda, K., Kustosik, N., Lisińska, W., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010096 · Cited by 87
Extracellular vesicles and lipoproteins – Smart messengers of blood cells in the circulation
Nguyen, P. H. D., Le, A. H., Pek, J. S. Q., Pham, T. T., Jayasinghe, M. K., Do, D. V., Phung, C. D., & Le, M. T. N. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.49 · Cited by 31
Metadata
- Authors
- Poznyak, A. V., Nikiforov, N. G., Markin, A. M., Kashirskikh, D. A., Myasoedova, V. A., Gerasimova, E. V., & Orekhov, A. N.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-01-11
- Volume
- 11
- Pages
- 613780-613780
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3120161822
- Cited by
- 370
- References
- 100
- FWCI
- 17.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.